MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 189 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2021. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,229,800 | +157.3% | 37,031 | +144.2% | 0.00% | – |
| Q3 2022 | $478,000 | +45.3% | 15,162 | +40.2% | 0.00% | – |
| Q2 2022 | $329,000 | -86.1% | 10,812 | -88.1% | 0.00% | -100.0% |
| Q1 2022 | $2,360,000 | +46.6% | 90,902 | +15.2% | 0.00% | – |
| Q4 2021 | $1,610,000 | -20.4% | 78,900 | -24.9% | 0.00% | -100.0% |
| Q3 2021 | $2,022,000 | -11.7% | 105,100 | +1.8% | 0.00% | – |
| Q2 2021 | $2,290,000 | +51.9% | 103,223 | +79.7% | 0.00% | – |
| Q1 2021 | $1,508,000 | +681.3% | 57,453 | +457.8% | 0.00% | – |
| Q4 2020 | $193,000 | -46.8% | 10,300 | -51.9% | 0.00% | – |
| Q3 2020 | $363,000 | -64.1% | 21,394 | -50.7% | 0.00% | -100.0% |
| Q2 2020 | $1,011,000 | +592.5% | 43,389 | +148.9% | 0.00% | – |
| Q1 2020 | $146,000 | +4.3% | 17,432 | +74.1% | 0.00% | – |
| Q4 2017 | $140,000 | – | 10,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |